Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

N. Homer; D. S. Grewal; R. G. Mirza; A. T. Lyon; M. K. Gill

doi:10.1038/eye.2015.191

Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

N. Homer, D. S. Grewal, R. G. Mirza, A. T. Lyon, M. K. Gill

Ophthalmology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1630-1631
Number of pages	2
Journal	Eye (London, England)
Volume	29
Issue number	12
DOIs	https://doi.org/10.1038/eye.2015.191
State	Published - Dec 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1038/eye.2015.191

Cite this

@article{fa948dba42134328839a6b1310bcfe43,

title = "Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'",

author = "N. Homer and Grewal, {D. S.} and Mirza, {R. G.} and Lyon, {A. T.} and Gill, {M. K.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1038/eye.2015.191",

language = "English (US)",

volume = "29",

pages = "1630--1631",

journal = "Eye (London, England)",

issn = "0950-222X",

publisher = "Nature Publishing Group",

number = "12",

}

Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'. / Homer, N.; Grewal, D. S.; Mirza, R. G. et al.
In: Eye (London, England), Vol. 29, No. 12, 01.12.2015, p. 1630-1631.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response to

T2 - 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

AU - Homer, N.

AU - Grewal, D. S.

AU - Mirza, R. G.

AU - Lyon, A. T.

AU - Gill, M. K.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84973500587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973500587&partnerID=8YFLogxK

U2 - 10.1038/eye.2015.191

DO - 10.1038/eye.2015.191

M3 - Letter

C2 - 26449193

SN - 0950-222X

VL - 29

SP - 1630

EP - 1631

JO - Eye (London, England)

JF - Eye (London, England)

IS - 12

ER -

Response to: 'Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results'

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this